Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study-Reference-Cited by-同舟云学术

Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study

Published:2011-07-12 Issue:3 Volume:219 Page:715-725
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Apostol George,Abi-Saab Walid,Kratochvil Christopher J.,Adler Lenard A.,Robieson Weining Z.,Gault Laura M.,Pritchett Yili L.,Feifel David,Collins Michelle A.,Saltarelli Mario D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-011-2393-2.pdf

Reference41 articles.

1. Adler L, Spencer T (2004). The Adult ADHD Clinical Diagnostic Scale (ACDS) V 1.2. New York: New York University School of Medicine

2. Adler LA, Spencer T, Faraone SV, Reimherr FW, Kelsey D, Michelson D, Biederman J (2005) Training raters to assess adult ADHD: reliability of ratings. J Atten Disord 8:121–126

3. Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, Biederman J (2008) Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 69:1364–1373

4. Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, Deldar A, Schuh K, Durell T (2009a) Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety 26:212–221

5. Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, Trzepacz PT, Williams DW, Kelsey D (2009b) Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol 29:44–50

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development;New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder;2022

2. Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology;Journal of Psychopharmacology;2021-07-28

3. Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD);Expert Opinion on Emerging Drugs;2020-09-25

4. Dissociation of nicotinic α7 and α4/β2 sub-receptor agonists for enhancing learning and attentional filtering in nonhuman primates;Psychopharmacology;2019-12-21

5. Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD);Expert Opinion on Pharmacotherapy;2019-05-21